ViaLongeVita

Klinická studie — Léčba a rakovinaVIP

Patients with cancer who received most of their immunotherapy treatments earlier in the day experienced longer overall survival than those who received their treatments later in the day. new findings suggest.1The findings made national headlines, but independent experts and the researchers of the study themselves have.

Obsah není lékařská diagnóza ani léčebné doporučení. Vždy konzultujte se svým lékařem.